Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Sell · Filed 06/09

Trade details

Type: Insider sale
Amount: $11,970,966.7
Shares · price: 49,670 sh · $241.01 a share
Held after: 7,229 sh
Stock: Axsome Therapeutics AXSM
Person: Herriot TabuteauCEO
Trade date: 26/06/09
Filed: 26/06/09
Days to filing: 0 days

Sold 87.3% of holdings

Share of holding sold: 87.3%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 05/10~07/09

Herriot Tabuteau's recent trades

Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
Herriot TabuteauCEO
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$6M
32,410 sh
$6M
Filed 02/02
Traded 02/02

Herriot Tabuteau, CEO — sold $12M of Axsome Therapeutics AXSM · 87.3% of holdings · 10b5-1 plan | Whalegun